Abstract
Background Amniocentesis is a technique for withdrawing amniotic fluid from the uterine cavity using a needle via a trans-abdominal approach. It has multiple diagnostic and therapeutic uses such as prenatal genetic studies and amnioreduction for polyhydramnios. The commonest indications are advanced maternal age and increased risk on maternal serum screening. The objective of this study is to review the common indications, outcomes and complications of amniocentesis at a tertiary hospital in Ethiopia.
Methods A retrospective cross-sectional study was conducted at a tertiary hospital in Ethiopia. Data was collected from the Fetomaternal division’s log records and follow-up charts during the time period of 2019 to 2022. All records of patients who had amniocentesis done were included in the study. Socio-demographic information and obstetric history and variables related to the procedures were retrieved. Descriptive statistics was done using the software IBM Statistical Package for Social Sciences (SPSS) version 25.
Results A total of 35 patients’ records were reviewed. The mean maternal age was 32 years (range, 19 – 43 years). The mean gestational age was 20.9 weeks (SD ± 2.2). The commonest indications for amniocentesis were previous history of Down syndrome (11%), advanced maternal age (9%) and QUAD 1:200 for Down syndrome (6%). Karyotype test was done in 29 of the 35 amniocentesis cases which was normal in 72% of the cases, 17% had Trisomy-21 and 11% had Trisomy-18. Fifty-two percent of the pregnancy had a live full term delivery and 25% of the cases terminated the pregnancy.
Conclusion The most common indications for amniocentesis in Ethiopia were abnormal ultrasound finding, advanced maternal age and abnormal QUAD test results. Around a quarter of the genetic tests which were done after the procedure had chromosomal abnormalities, from which, the majority were terminated. There was no complication related to the procedure.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Myungsung Medical College Ethics Review Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* First author
Data Availability
The data underlying the results presented in the study are available from the MCM Comprehensive Specialized Hospital data access.
